Stent grafts improved patency of ruptured hemodialysis vascular accesses

Min-Tsun Liao1,2, Chien-Ming Luo2,3, Ming-Chien Hsieh1

  • 1Division of Cardiology, Department of Medicine, National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan, ROC.

Scientific Reports
|January 8, 2022
PubMed

Insights

Stent grafts significantly improve target lesion patency for ruptured dialysis access compared to balloon tamponade. This endovascular repair method offers a durable solution, extending time to reintervention for patients undergoing dialysis access procedures.

Area of Science:

  • Interventional Nephrology
  • Vascular Surgery
  • Medical Device Technology

Background:

  • Rupture of dialysis access during percutaneous transluminal angioplasty is a complication requiring effective management.
  • Traditional methods like balloon tamponade have limitations in achieving long-term patency.
  • Stent grafts offer a potential alternative for sealing these ruptures.

Purpose of the Study:

  • To compare the efficacy of stent graft repair versus balloon tamponade for managing ruptured dialysis access.
  • To evaluate target lesion primary patency and access circuit patency at 6 and 12 months post-intervention.

Main Methods:

  • Retrospective analysis of 143 patients with ruptured dialysis access from 2010-2018.
  • Comparison of outcomes between 52 patients treated with stent grafts and 91 patients treated with balloon tamponade.
  • Primary endpoint: target lesion primary patency at 12 months.

Main Results:

  • Stent graft group showed significantly higher 6-month (66.7% vs. 29.5%) and 12-month (52.5% vs. 9.0%) target lesion primary patency.
  • Stent grafts increased median time to reintervention by 171 days (260 vs. 89 days).
  • No significant difference in access circuit patency rates at 6 and 12 months between the groups.

Conclusions:

  • Stent grafts provide superior target lesion primary patency for ruptured dialysis access compared to balloon tamponade.
  • Stent graft repair is a durable solution that prolongs the time to subsequent interventions.
  • While access circuit patency was similar, stent grafts offer a significant advantage in lesion-specific outcomes.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
391
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
178
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
46